通过选择基因驱动程序编程瘤进化,积极打击耐药性
Scott M Leighow1,2, Joshua A Reynolds1, Ivan Sokirniy1,2
1Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA.
Nature biotechnology
|July 4, 2024
概括
这项研究引入了选择基因驱动器,以重定向瘤进化和克服耐药性. 这些工程系统在体外和体内有效地消除了各种癌症抵抗机制.
科学领域:
- 在瘤学瘤学.
- 进化生物学 进化生物学
- 合成生物学 合成生物学
背景情况:
- 针对性抗癌疗法经常由于药物耐药性的演变而失败.
- 瘤的遗传异质性使普遍有效的癌症治疗方法的开发变得复杂.
研究的目的:
- 设计一种新的治疗策略,可重复地重定向瘤进化以克服药物耐药性.
- 开发和验证用于癌症治疗的选择基因驱动系统.
主要方法:
- 开发一种选择基因驱动系统,具有可诱导的健身优势和共享的健身成本开关.
- 使用随机模型来定义选择基因驱动设计标准.
- 原型驱动器利用氨酸激酶抑制剂和多种治疗机制 (原药催化,免疫诱导).
- 在体外和体外 (小鼠模型) 对先前存在的遗传耐药性的测试.
主要成果:
- 选择基因驱动可以稳定地引入癌细胞.
- 设计的驱动器成功地在体外消除了各种遗传抵抗机制.
- 基于模型的驱动器应用有效地针对小鼠实体瘤模型中预先存在的抵抗.
结论:
- 选择基因驱动器代表了抗癌治疗的强大,以进化为导向的框架.
- 这种方法提供了一种可重复的方法,通过重定向瘤进化来设计治疗机会.
- 该战略有望克服各种癌症的耐药性.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
09:01Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
Published on: March 16, 2011
30.5K
相关概念视频
Antibiotic Selection
53.0K
Overview
53.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Genome Size and the Evolution of New Genes
7.9K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
7.9K
Mutation, Gene Flow, and Genetic Drift
58.3K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
58.3K
Gene Flow
35.0K
Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
35.0K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
